FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Erika Hitre

Research Profile

Disorders

Procedures

Chemicals & Drugs

Geographic Areas

Hungary

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Sherene Loi; Stefan Michiels; Martine J Piccart; Fanny Piette; Emmanuel Quinaux; Ghizlane Rouas; Roberto Salgado; Nicolas Sirtaine; John P A Crown; Evandro de Azambuja; Angelo Di Leo; Prudence Francis; Erika Hitre; Françoise Van Eenoo; Giuseppe Viale; C Sotiriou
Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98.
István Láng; Philippe Rougier; Ute Sartorius; Desmond Curran; Gunnar Folprecht; Ingolf Griebsch; Erika Hitre; Claus-Henning Köhne; Eric Van Cutsem
Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin.
Barna Budai; István Láng; T Nagy; Erika Hitre
The use of high dose d,l-leucovorin in first-line bevacizumab+mFOLFIRI treatment of patients with metastatic colorectal cancer may enhance the antiangiogenic effect of bevacizumab.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Erika Hitre (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sherene Loi; Stefan Michiels; Martine J Piccart; Fanny Piette; Emmanuel Quinaux; Ghizlane Rouas; Roberto Salgado; Nicolas Sirtaine; John P A Crown; Evandro de Azambuja; Angelo Di Leo; Prudence Francis; Erika Hitre; Françoise Van Eenoo; Giuseppe Viale; C Sotiriou
Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(7):860-7.
2013: István Láng; Philippe Rougier; Ute Sartorius; Desmond Curran; Gunnar Folprecht; Ingolf Griebsch; Erika Hitre; Claus-Henning Köhne; Eric Van Cutsem
Quality of life analysis in patients with KRAS wild-type metastatic colorectal cancer treated first-line with cetuximab plus irinotecan, fluorouracil and leucovorin.
European journal of cancer (Oxford, England : 1990) 2013;49(2):439-48.
2013: Barna Budai; István Láng; T Nagy; Erika Hitre
The use of high dose d,l-leucovorin in first-line bevacizumab+mFOLFIRI treatment of patients with metastatic colorectal cancer may enhance the antiangiogenic effect of bevacizumab.
Angiogenesis 2013;16(1):113-21.
2012: Eva Jederán; István Láng; József Lövey; Zoltán Mátrai; György Naszádos; László Tóth; Erika Hitre; Mária Gõdény
[Role of MRI in determining the therapy of rectal cancer].
Magyar onkologia 2012;56(3):179-86.
2011: Shoaib Afzal; Jon Trærup Andersen; Carmen Barile; Laura Bertolaso; Kasper Brødbæk; Barna Budai; Milena Gusella; Erika Hitre; Søren Astrup Jensen; Espen Jimenez-Solem; Judit Kralovánszky; István Láng; Eniko Orosz; Roberto Padrini; Felice Pasini; Morten Petersen; Ben Vainer; Ulla Vogel; Vilmos Adleff; Henrik Enghusen Poulsen
The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer.
Pharmacogenomics 2011;12(9):1257-67.
2011: Zsolt Horváth; Eva Juhos; Ferenc Czeglédi; Sándor Eckhardt; Erna Ganofszky; Erika Hitre; István Láng; Csaba Polgár; Laszlo Torday; László Urbán; Miklós Kásler
Inflammatory breast cancer-comparing the effectivity of preoperative docetaxel-epirubicine protocol to conventional antracycline-containing chemotherapy to achieve clinical benefit and complete pathological response.
Pathology oncology research : POR 2011;17(3):541-50.
2010: Viktor Komlósi; Erika Hitre; Eva Pap; Vilmos Adleff; Andrea Réti; Eszter Székely; Anna Bíró; Péter Rudnai; Bernadette Schoket; Judit Müller; Béla Tóth; Szabolcs Ottó; Miklós Kásler; Judit Kralovánszky; Barna Budai
SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer.
BMC cancer 2010;10():525.
2009: Zoltán Mátrai; Gabriella Liszkay; Vanda Plotár; Orosz Zsolt; Judit Székely; Erika Hitre; Alexandra Bartal; Zoltán Langmár; Katalin Bocs; Ferenc Rényi-Vámos; Akos Sávolt; László Tóth
[Long-term experience with multidisciplinary therapy of twenty-six patients with dermatofibrosarcoma protuberans].
Orvosi hetilap 2009;150(41):1894-902.
2009: Eric Van Cutsem; Claus-Henning Köhne; Erika Hitre; Jerzy Zaluski; Chung-Rong Chang Chien; Anatoly Makhson; Geert D'Haens; Tamás Pintér; Robert Lim; György Bodoky; Jae Kyung Roh; Gunnar Folprecht; Paul Ruff; Christopher Stroh; Sabine Tejpar; Michael Schlichting; Johannes Nippgen; Philippe Rougier
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.
The New England journal of medicine 2009;360(14):1408-17.
2009: Zoltán Mátrai; Janos Papp; Csaba Polgár; Erika Hitre; István Köves; Edit Oláh; Judit Andi; Andrea Kiss; István Vámosi Nagy; László Tóth; Orosz Zsolt
[Long-term experience with therapy of a female patient with Gardner's syndrome, first presenting with extra-abdominal desmoid tumor, and review of the literature].
Magyar sebészet 2009;62(2):75-82.
2009: Hiroto Nakadaira; Istvan Lang; Zoltan Szentirmay; Erika Hitre; Miklos Kaster; Masaharu Yamamoto
A case-control study of gallbladder cancer in hungary.
Asian Pacific journal of cancer prevention : APJCP 2009;10(5):833-6.
2008: Krisztián Bácsi; Erika Hitre; János P Kósa; Henrik Csaba Horváth; Áron Lazáry; Péter László Lakatos; Bernadett Balla; Barna Budai; Péter Lakatos; Gábor Speer
Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population.
BMC cancer 2008;8():317.
2007: Thomas M Suter; Marion Procter; Dirk J van Veldhuisen; Michael Muscholl; Jonas Bergh; Chiara Carlomagno; Timothy Perren; Rodolfo Passalacqua; Claudia Bighin; Jan G M Klijn; Fail T Ageev; Erika Hitre; Juergen Groetz; Hiroji Iwata; Malgorzata Knap; Michael Gnant; Susanne Muehlbauer; Alison Spence; Richard D Gelber; Martine J Piccart-Gebhart
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3859-65.
2007: Judit Kralovánszky; Vilmos Adleff; Erika Hitre; Eva Pap; Andrea Réti; Viktor Komlósi; Barna Budai
[Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
Magyar onkologia 2007;51(2):113-25.
2007: Péter Lakatos; Erika Hitre; Ferenc Szalay; Kerstin Zinober; Péter Fuszek; Laszlo Lakatos; Simon Fischer; Janos Osztovits; Orsolya Gemela; Gábor Veres; Janos Papp; Peter Ferenci
Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients.
BMC cancer 2007;7():54.
2006: Zoltán Mátrai; József Lövey; Erika Hitre; Orosz Zsolt; Mária Gödény; Gábor Péley; Zoltán Sulyok; Ferenc Rényi-Vámos; Emil Farkas; István Köves
[Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
Orvosi hetilap 2006;147(42):2011-20.
2006: Péter Fuszek; Henrik Csaba Horváth; Gábor Speer; Janos Papp; Petra Haller; Judit Halász; Balázs Járay; Eszter Székely; Zsuzsa Schaff; András Papp; Attila Bursics; László Harsányi; Péter Lukovich; Péter Kupcsulik; Erika Hitre; Péter Lakatos
[Change in location of colorectal cancer in Hungarian patients between 1993-2004].
Orvosi hetilap 2006;147(16):741-6.
2006: István Láng; Erika Hitre
[Trastuzumab (Herceptin) in the adjuvant treatment of HER-2-positive early breast cancer].
Magyar onkologia 2006;50(4):293-302.
2006: Péter Fuszek; Henrik Csaba Horváth; Gábor Speer; Janos Papp; Petra Haller; Simon Fischer; Judit Halasz; Balázs Járay; Eszter Szekely; Zsuzsa Schaff; András Papp; Attila Bursics; Laszlo Harsanyi; Péter Lukovich; Péter Kupcsulik; Erika Hitre; Péter Lakatos
Location and age at onset of colorectal cancer in Hungarian patients between 1993 and 2004. The high number of advanced cases supports the need for a colorectal cancer screening program in Hungary.
Anticancer research 2006;26(1B):527-31.
2006: Gábor Péley; Klára Török; Emil Farkas; Zoltán Mátrai; Zsolt Horváth; István Sinkovics; Erika Hitre; Ferenc Rényi-Vámos; Orosz Zsolt; István Köves
[The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
Magyar onkologia 2006;50(1):19-23.
2005: Erika Hitre; Barna Budai; Vilmos Adleff; Ferenc Czeglédi; Zsolt Horváth; Fruzsina Gyergyay; József Lövey; Tibor Kovács; Orosz Zsolt; István Láng; Miklós Kásler; Judit Kralovánszky
Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil.
Pharmacogenetics and genomics 2005;15(10):723-30.
2005: István Láng; Erika Hitre
[Current aspects of treatment in gastrointestinal stromal tumors (GIST)].
Orvosi hetilap 2005;146(18 Suppl 1):935-41.
2004: Vilmos Adleff; Erika Hitre; István Köves; Orosz Zsolt; Anna Hajnal; Judit Kralovánszky
Heterozygote deficiency in thymidylate synthase enhancer region polymorphism genotype distribution in Hungarian colorectal cancer patients.
International journal of cancer. Journal international du cancer 2004;108(6):852-6.
2004: István Láng; Erika Hitre
[Recent results of irinotecan therapy in colorectal cancer].
Magyar onkologia 2004;48(4):281-8.
2004: Barna Budai; Erika Hitre; Vilmos Adleff; Ferenc Czeglédi; Fruzsina Gyergyay; István Láng; Judit Kralovánszky
[The clinical importance of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the 5-fluoropyrimidine-based therapy of metastatic colorectal tumours].
Magyar onkologia 2004;48(3):253-7.
2003: István Láng; Erika Hitre; Zsolt Horváth; Mária Godény
Case 3. Resection of originally inoperable liver metastases of gastrointestinal stromal tumor after imatinib mesylate therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3538-40.
1998: Zoltan Vajo; Béla Székács; Erika Hitre; Z Jakab; K Balint
Supraclavicular abscess caused by Salmonella enteritidis in patient without gastrointestinal symptoms.
Wiener klinische Wochenschrift 1998;110(22):802-3.